Results 191 to 200 of about 749,263 (385)

Vascular Endothelial Growth Factor A (VEGF-A) and Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2) as Potential Biomarkers for Oral Squamous Cell Carcinoma: A Sri Lankan Study. [PDF]

Asian Pac J Cancer Prev, 2023
Edirisinghe ST, Weerasekera M, De Silva DK, Devmini MT, Pathmaperuma S, Wijesinghe GK, Nisansala T, Maddumage A, Huzaini H, Rich AM, De Silva H, Trudy M, Goonasinghe R, De Silva K, Yasawardena S.   +14 more
europepmc   +1 more source

Vascular endothelial growth factor (VEGF) impairs the motility and immune function of human mature dendritic cells through the VEGF receptor 2‐RhoA‐cofilin1 pathway [PDF]

, 2019
Jinhua Long, Zuquan Hu, Hui Xue, Yun Wang, Jin Chen, Fuzhou Tang, Jing Zhou, Lina Liu, Wei Qiu, Shichao Zhang, Yan Ouyang, Yuannong Ye, Guoqiang Xu, Long Li, Zhu Zeng   +14 more
openalex   +1 more source

Coagulative Granular Hydrogels with an Enzyme Catalyzed Fibrin Network for Endogenous Tissue Regeneration

Advanced Healthcare Materials, EarlyView.
Coagulative granular hydrogels are composed of packed thrombin‐functionalized microgels that catalyze the conversion of fibrinogen into a secondary fibrin network, filling the interstitial voids. This bio‐inspired approach stabilizes the biomaterial to match the robustness of bulk hydrogels without compromising injectability, mimicking the initial ...
Zhipeng Deng, Camila B. Tovani, Simona Bianco, Gianni Comandini, Aya Elghajiji, Mina Aleemardani, Roxana Moscalu, Jeremie Zappia, Bianca Fernandes, Olivia Annett, Chrissy L. Hammond, Jason Wong, Dave J. Adams, Fabrizio Scarpa, Michael R. Whitehouse, Annela M. Seddon, James P. K. Armstrong   +16 more
wiley   +1 more source

Soluble vascular endothelial growth factor receptor 2 and prognosis in patients with chronic heart failure. [PDF]

ESC Heart Fail, 2021
Iguchi M, Wada H, Shinozaki T, Suzuki M, Ajiro Y, Matsuda M, Koike A, Koizumi T, Shimizu M, Ono Y, Takenaka T, Sakagami S, Morita Y, Fujimoto K, Yonezawa K, Yoshida K, Ninomiya A, Nakamura T, Funada J, Kajikawa Y, Oishi Y, Kato T, Kotani K, Abe M, Akao M, Hasegawa K, PREHOSP-CHF Study Investigators.   +26 more
europepmc   +1 more source

Vascular endothelial growth factor receptor 2 expression in non-tumorous cirrhotic liver is higher when hepatoma is beyond milan criteria [PDF]

, 2009
Federico Aucejo, Richard D. Kim, Nizar N. Zein, Cristiano Quintini, Teresa Diago Uso, Rocío López, Bijan Eghtesad, John J. Fung, Charles M. Miller, Lisa Yerian   +9 more
openalex   +1 more source

Intraoperative Near-Infrared Fluorescence Tumor Imaging with Vascular Endothelial Growth Factor and Human Epidermal Growth Factor Receptor 2 Targeting Antibodies

Journal of Nuclear Medicine, 2011
A. T. V. Terwisscha van Scheltinga, G. V. van Dam, W. Nagengast, V. Ntziachristos, H. Hollema, J. Herek, C. Schröder, J. Kosterink, Marjolijn N Lub-de Hoog, E. D. de Vries   +9 more
semanticscholar   +1 more source

Cell Calcification Models and Their Implications for Medicine and Biomaterial Research

Advanced Healthcare Materials, EarlyView.
Calcification, is the process by which the tissues containing minerals are formed, occurring during normal physiological processes, or in pathological conditions. Here, it is aimed to give a comprehensive overview of the range of cell models available, and the approaches taken by these models, highlighting when and how methodological divergences arise,
Luke Hunter, Caterina Vanelli Coralli, Robert Dzhanaev, Aaron Morgan, Willi Jahnen‐Dechent, Sergio Bertazzo   +5 more
wiley   +1 more source

Clinical utility of ramucirumab in advanced gastric cancer

Biologics: Targets & Therapy, 2015
Matthew MK Chan,1,2 Katrin M Sjoquist,1,3 John R Zalcberg4 1NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia; 2Department of Medical Oncology, Central Coast Cancer Centre, Gosford Hospital, Gosford, NSW, Australia; 3Cancer Care ...
Chan MMK, Sjoquist KM, Zalcberg JR
doaj  

Peroxisome-proliferator-activated receptor α agonists inhibit cyclo-oxygenase 2 and vascular endothelial growth factor transcriptional activation in human colorectal carcinoma cells via inhibition of activator protein-1 [PDF]

, 2006
Raquel Grau, Carmen Punzón, Manuel Fresno, Miguel A. Íñiguez   +3 more
openalex   +1 more source

AZD2171: a highly potent, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for the treatment of cancer.

Cancer Research, 2005
S. Wedge, J. Kendrew, L. Hennequin, P. J. Valentine, S. Barry, S. Brave, N. Smith, N. James, M. Dukes, J. Curwen, R. Chester, J. Jackson, S. Boffey, Lyndsey L. Kilburn, S. Barnett, Graham H. P. Richmond, P. Wadsworth, Mike Walker, Alison L. Bigley, S. Taylor, L. Cooper, Sarah Beck, J. Jürgensmeier, D. Ogilvie   +23 more
semanticscholar   +1 more source